Cargando…
Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152121/ https://www.ncbi.nlm.nih.gov/pubmed/34039290 http://dx.doi.org/10.1186/s12885-021-08369-4 |
_version_ | 1783698539531993088 |
---|---|
author | Hawarden, Amy Russell, Bryn Gee, Mary Ellen Kayali, Fatima Clamp, Andrew Crosbie, Emma Jayne Edmondson, Richard John |
author_facet | Hawarden, Amy Russell, Bryn Gee, Mary Ellen Kayali, Fatima Clamp, Andrew Crosbie, Emma Jayne Edmondson, Richard John |
author_sort | Hawarden, Amy |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8152121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81521212021-05-26 Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study Hawarden, Amy Russell, Bryn Gee, Mary Ellen Kayali, Fatima Clamp, Andrew Crosbie, Emma Jayne Edmondson, Richard John BMC Cancer Correction BioMed Central 2021-05-26 /pmc/articles/PMC8152121/ /pubmed/34039290 http://dx.doi.org/10.1186/s12885-021-08369-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Hawarden, Amy Russell, Bryn Gee, Mary Ellen Kayali, Fatima Clamp, Andrew Crosbie, Emma Jayne Edmondson, Richard John Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title | Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title_full | Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title_fullStr | Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title_full_unstemmed | Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title_short | Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
title_sort | correction to: factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152121/ https://www.ncbi.nlm.nih.gov/pubmed/34039290 http://dx.doi.org/10.1186/s12885-021-08369-4 |
work_keys_str_mv | AT hawardenamy correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT russellbryn correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT geemaryellen correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT kayalifatima correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT clampandrew correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT crosbieemmajayne correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy AT edmondsonrichardjohn correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy |